BML Capital Management, LLC — 13F Holdings & Portfolio

CIK 1616824 · latest 13F-HR filed 2026-11-06

BML Capital Management, LLC manages $187.6M in 13F-reported U.S. long-equity assets across 20 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are ACRS (30.71%), AVIR (18.75%), ENGN (7.11%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 3 new positions and exited 0; 7 existing positions rose in reported value and 5 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$187.6M

Long-equity book

Holdings
20

Distinct positions

Period
2026-09-30

Filed 2026-11-06

Q/Q Activity
+3 / −0 / ↑7 / ↓5

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 89.6%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 25, 2026.

Address
65 E CEDAR
SUITE 2
ZIONSVILLE, IN 46077
Phone
(317) 344-2447
Name Title / Status Ownership Type
LEONARD, BRADEN, MICHAEL ControlMEMBER
since Sep 2004
75% or moreIndividual

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 7 →

Top Trims

Show all 5 →

Exited Positions

  • No exits this quarter.
Show all 0 →

BML Capital Management, LLC Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ACLARIS THERAPEUTICS INC ACRS 00461U105 $57.6M 30.71% 10,955,000 SH
2 ATEA PHARMACEUTICALS INC AVIR 04683R106 $35.2M 18.75% 6,753,658 SH
3 ENGENE THERAPEUTICS INC ENGN 29286X101 $13.3M 7.11% 6,669,908 SH
4 PMV PHARMACEUTICALS INC PMVP 69353Y103 $12.2M 6.52% 7,330,000 SH
5 KRAFT HEINZ CO KHC 500754106 $10.8M 5.75% 475,000 SH
6 TILLYS INC TLYS 886885102 $10.0M 5.31% 2,150,000 SH
7 CARMAX INC KMX 143130102 $9.5M 5.07% 172,500 SH
8 OUTSET MED INC OM 690145206 $7.6M 4.03% 2,519,701 SH
9 TARGET CORP TGT 87612E106 $5.9M 3.13% 37,500 SH
10 SEER INC SEER 81578P106 $4.9M 2.60% 2,186,587 SH
11 INSTIL BIO INC TIL 45783C200 $4.7M 2.49% 645,600 SH
12 CONNECT BIOPHARMA HLDGS LTD CNTB G23549101 $4.3M 2.27% 3,864,400 SH
13 ORAMED PHARMACEUTICALS INC ORMP 68403P203 $4.1M 2.20% 884,392 SH
14 JANUX THERAPEUTICS INC JANX 47103J105 $2.6M 1.39% 151,126 SH
15 PLIANT THERAPEUTICS INC PLRX 729139105 $1.7M 0.89% 1,546,137 SH
16 LENZ THERAPEUTICS INC LENZ 52635N103 $1.1M 0.58% 283,114 SH
17 IMAGENEBIO INC IMA 45175G207 $919.3K 0.49% 200,730 SH
18 TESLA INC Put TSLA 88160R101 $696.0K 0.37% 150 SH
19 WALMART INC Put WMT 931142103 $537.7K 0.29% 335 SH
20 KARYOPHARM THERAPEUTICS INC KPTI 48576U205 $87.6K 0.05% 71,839 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-06 $187.6M 20 0001754960-26-000981
2026-06-30 2026-08-07 $176.1M 18 0001754960-26-000696
2026-03-31 2026-05-06 $155.8M 16 0001754960-26-000359
2025-12-31 2026-02-03 $115.7M 16 0001754960-26-000146
Filer Information
Address
65 E CEDAR - SUITE 2
ZIONSVILLE, IN 46077
Phone
(317) 344-2447
Filing Manager
BML Capital Management, LLC
ZIONSVILLE, IN
Signatory
Aryn Sands
Agent